Formula derived from computer analysis forecasts AMD

111814

Researchers at Standford University School of Medicine have developed a formula based on analyzing computer imaging data that is gathered in eye doctors’ offices to determine which patients are most likely to develop the advanced form of macular degeneration. The research was documented in Investigative Ophthamology & Visual Sciences. The formula is based upon computer […]

Eylea on FDA fast track for diabetic retinopathy treatment

092514

Regeneron Pharmaceuticals announced that the FDA has classified Eylea as a breakthrough therapy to treat diabetic retinopathy in patients who already have diabetic macular edema.This classification expedites the process for Eylea to be FDA approved. Currently, Eylea has FDA approval for treatment of wet age-related macular degeneration, macular edema associated with central retinal vein occlusion […]

Reticular pseudodrusen found to be a risk factor for wet AMD

090214

Researchers at the University of Melbourne have found a link between reticular pseudodrusen (RPD) and an increased risk of developing the wet form of macular degeneration. The study involved 200 patients with choroidal neovascularisation (CNV) secondary to age-related macular degeneration in one eye but with no signs of wet AMD in the other eye. The […]

UK Teaching hospitals using new wet AMD treatment

082614

Some wet AMD patients in the United Kingdom are now receiving a new, non-invasive treatment for their disease. The new treatment known as Oraya Therapy™ is being used by eye specialists at the Sheffield’s Royal Hallamshire Hospital. This new therapy is painless and delivers highly targeted, low-energy X-rays to the eye. The amount of radiation […]

Hepatic Lipase Gene may reduce risk of Macular Degeneration

072214-1

Researchers reviewed data from 10 case-control studies that included advanced AMD  (choroidal neovascularization or geographic atrophy)  patients that had undergone genotyping. They were looking for a relationship between the LIPC variant and advanced AMD. The results were published in the online JAMA Ophthalmology on July 10. What this review revealed is that the risk of […]

Reticular drusen 4x more likely to develop wet macular degeneration

reticular drusen

  University of Sydney researchers have discovered a link between reticular drusen and the progression of macular degeneration. Patients in the study that had reticular drusen were four times more likely to go on to develop the wet form of macular degeneration than those who did not have reticular drusen. Patients who increased their dietary […]

Could blood pressure meds raise risk of developing AMD?

061714

A recent, long-term study points to a possible link between vasodilators and beta blockers and the development of age-related macular degeneration (AMD). Researchers at the University of Wisconsin School of Medicine conducted a 25-year study, which included t 5,000 adults who were between the ages of 43 and 86. Eye exams were conducted every 5 […]

FDA approves device to monitor AMD at home

050814

The FDA has given its approval to the ForeseeHome home monitoring system that will allow patients to keep track of the progression of their AMD at home. Daily monitoring can play an important role in determining if the macular degeneration has advanced from the dry form of AMD to the more serious wet form, which […]

Single shot gene therapy could benefit wet AMD patients

052014

Researchers at the Lions Eye Institute in Perth, Western Australia have created a new gene therapy that could potentially replace invasive monthly injections, which are the current method of treating the wet form of macular degeneration. A single injection carries a benign, modified virus which has a gene that creates a supply of a protein […]

IL-18 component offers hope for Macular Degeneration

041514

The online journal, Science of Translational Medicine, details the breakthrough discovery of a component of the immune system known as IL-18 that may hold the key to treating macular degeneration. Researchers at Trinity College in Dublin discovered that IL-18 acts as a “guardian of eyesight” by suppressing the production of damaging blood vessels behind the […]